Nutriband Inc. (NASDAQ:NTRB – Get Free Report) was the recipient of a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 56,300 shares, a decrease of 14.3% from the May 31st total of 65,700 shares. Based on an average trading volume of 62,000 shares, the days-to-cover ratio is presently 0.9 days. Approximately 1.0% of the shares of the stock are sold short.
Nutriband Price Performance
NASDAQ:NTRB opened at $5.40 on Friday. The stock has a fifty day moving average price of $4.69 and a 200-day moving average price of $3.56. The company has a current ratio of 6.16, a quick ratio of 6.04 and a debt-to-equity ratio of 0.03. Nutriband has a fifty-two week low of $1.53 and a fifty-two week high of $6.75.
Nutriband (NASDAQ:NTRB – Get Free Report) last released its earnings results on Friday, May 31st. The company reported ($0.21) earnings per share for the quarter. The company had revenue of $0.41 million for the quarter. Nutriband had a negative net margin of 315.56% and a negative return on equity of 71.77%.
Institutional Trading of Nutriband
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Further Reading
- Five stocks we like better than Nutriband
- 3 Monster Growth Stocks to Buy Now
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- What is a Bond Market Holiday? How to Invest and Trade
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- 3 Grocery Stocks That Are Proving They Are Still Essential
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.